Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00785525 · ClinicalTrials.gov registry record · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
A Phase 3 study of Healthy, sponsored by Center for International Blood and Marrow Transplant Research.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 60,000
- Enrollment target
- 4
- Study locations
NCT00785525: Recruiting Phase 3 study of Healthy, sponsored by Center for International Blood and Marrow Transplant Research.
NCT00785525 is a Phase 3 study of Healthy that is actively recruiting participants, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 60,000 participants, above the 592-participant average among 1,090 other Healthy trials with a reported enrollment target (10035% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00785525, a Phase 3 study of Healthy, is actively recruiting participants, sponsored by Center for International Blood and Marrow Transplant Research.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 60,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess the safety among NMDP donors of filgrastim administration and PBSC leukapheresis * Assess the safety and efficacy of filgrastim-mobilized PBSC in unrelated donor hematopoietic stem cell transplant recipients * Determine the acceptability of stem cell donation by filgrastim stimulated apheresis in normal donors
Conditions Studied
Interventions
- DRUG Filgrastim
Study Locations (4)
Florida
- Gift of Life Bone Marrow Foundation - Boca Raton
Maryland
- C.W. Bill Young Marrow Donor Center - Rockville
Minnesota
- Be The Match - Minneapolis
New York
- DKMS Americas - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 1997-02 |
| Est. Completion | 2030-01 |
| Phase | Phase 3 |
What NCT00785525 shows while recruiting
NCT00785525 is an interventional study that assigns participants to a tested intervention. Its 60,000 participants enrollment target places it among the larger protocols in the corpus, above the 592-participant average among 1,090 other Healthy trials with a reported enrollment target (10035% higher).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Filgrastim is the first listed.
NCT00785525 reports a single indexed study location in Florida, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00785525 about?
NCT00785525 is a clinical study titled "Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors". The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess the safety among NMDP donors of filgrastim administration and PBSC leukapheresis * Assess the safety ...
What is the current status of trial NCT00785525?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 60,000 participants. The study started on 1997-02. Estimated completion is 2030-01.
What conditions does trial NCT00785525 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00785525?
The interventions under investigation include: Filgrastim (DRUG).
Who is sponsoring clinical trial NCT00785525?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00785525 being conducted?
This trial has 4 study locations across Florida, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00785525's enrollment target sits among peer trials
60,000 4th of 1090 higher than 1,087 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
RECRUITING · Phase 3
-
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
COMPLETED · Phase 3
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
COMPLETED · Phase 3
-
Study to Investigate the Potential of Probiotics in Yogurt
COMPLETED · Phase 3
-
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
COMPLETED · Phase 3
-
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia